• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:陈鸿翔,毛建丰,盛荣.替诺福韦艾拉酚胺半D-(-)-酒石酸盐的制备及其稳定性研究[J].中国现代应用药学,2017,34(7):978-981.
CHEN Hongxiang,MAO Jianfeng,SHENG Rong.Preparation and Stability Research of Tenofoviral Afenamide D-(-)-Tartaric Acid Salt (2:1)[J].Chin J Mod Appl Pharm(中国现代应用药学),2017,34(7):978-981.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2647次   下载 2144 本文二维码信息
码上扫一扫!
分享到: 微信 更多
替诺福韦艾拉酚胺半D-(-)-酒石酸盐的制备及其稳定性研究
陈鸿翔1,2, 毛建丰2, 盛荣1
1.浙江大学药学院, 杭州 310058;2.杭州和泽医药科技有限公司, 杭州 310018
摘要:
目的 制备替诺福韦艾拉酚胺半D-(-)-酒石酸盐,并开展稳定性研究。方法 以替诺福韦(PMPA)为原料,经亚磷酸三苯酯缩合、二氯亚砜氯代、L-丙氨酸异丙酯缩合制得替诺福韦艾拉酚胺,再与D-(-)-酒石酸成盐。结果 制得的替诺福韦艾拉酚胺半D-(-)-酒石酸盐,经1H-NMR、31P-NMR、MS确证结构,并与半富马酸盐进行稳定性比较。结论 替诺福韦艾拉酚胺半D-(-)-酒石酸盐比半富马酸盐具有更好的稳定性,值得进一步开发。
关键词:  替诺福韦艾拉酚胺  替诺福韦  D-(-)-酒石酸  稳定性
DOI:10.13748/j.cnki.issn1007-7693.2017.07.010
分类号:
基金项目:
Preparation and Stability Research of Tenofoviral Afenamide D-(-)-Tartaric Acid Salt (2:1)
CHEN Hongxiang1,2, MAO Jianfeng2, SHENG Rong1
1.College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China;2.Hangzhou Heze Pharmaceutical Technology Co., Ltd., Hangzhou 310018, China
Abstract:
OBJECTIVE To prepare tenofoviralafenamide D-(-)-tartaric acid salt (2:1) and to study its stability.METHODS Tenofovir (PMPA) was utiliazed as the starting material,condensed with triphenylphosphite,chlorinated by thionyl chloride,and then condensed with L-alanine isopropyl to obtain tenofoviralafenamide.Tenofoviralafenamide was reacted with D-(-)-tartaric acid to form the salt.RESULTS The chemical structure of tenofoviralafenamide D-(-)-tartaric acid salt (2:1) was confirmed by 1H-NMR,31P-NMR,MS.The stability of the compound was also studied and compared with tenofoviralafenamide hemifumarate.CONCLUSION The results showed that D-(-)-tartaric acid salt has a better effect on stability than hemifumarate salt.It is worthy to be futher developed.
Key words:  tenofoviralafenamide  D-(-)-tartaric acid  stability
扫一扫关注本刊微信